Public Meeting Notice

Public Meeting Notice Board of Registration in Pharmacy meeting — August 4, 2022

Thursday, August 4, 2022 at 8 a.m.
  • Posted: June 3, 2022 11:35 a.m.
  • Last Updated: August 12, 2022 10:39 a.m.

Overview of Board of Registration in Pharmacy meeting — August 4, 2022

This meeting will be held via Webex conference call.

Webex information

Telephone information

  • Call in number: 1-650-479-3208
  • Access code: 2539 172 3512
  • Attendee: #

Agenda

Time

#

                                                             Item

8:00

I

CALL TO ORDER

8:02

II

APPROVAL OF AGENDA

8:05

III

APPROVAL OF BOARD MINUTES

  • Draft of June 2, 2022 Regular Session Minutes

8:10

IV

REPORTS

  • Applications approved pursuant to Licensure Policy 13-01
  • Monthly report from Probation         
  • Board Delegated Review pursuant to Licensure Policy 14-02
  • PSUD Report-Policy 17-03
  • Research Drug Study report pursuant to Staff Action Policy 18-02

8:20

V

FLEX

  • Pharmacy issues related to COVID-19
  • APhA Institute on Substance Use Disorders Overview
  • NABP Executive Committee District Nominations

8:30

VI

APPLICATIONS

  • Walgreens Central Fill– Request for temporary pharmacy
  • Walmart-Petition for waiver
  • Rite Aid- Petition for waiver
  • Cornerstone Health Solutions (DS90083): Petition for central fill and pilot project request
  • Steward Employee Pharmacy- New Community Pharmacy
  • New Health Charlestown Pharmacy – New Community Pharmacy
  • UMass Specialty Pharmacy (DS89822)- Renovation-Expansion
  • Upham’s Community Care - Pharmacy - New Community Pharmacy

10:00

VII

POLICY

Policy 22-xx:  Expedited Processing of Reciprocal License Applications in response to disease outbreak or other critical public health concern

10:30

VIII

FILE REVIEW

1

CAS-2021-0685

PHA-2022-0016

Option Care, DS90107

2

CAS-2021-1271

PHA-2021-0119

Big Y #65, DS3276

3

CAS-2022-0009

PHA-2022-0004

Walgreens #6072, DS3004

4

CAS-2021-0975

PHA-2022-0119

Innocent Akani, PH25261

5

CAS-2021-1140

SA-INV-19031

Edge Pharma, NO00015      

6

CAS-2022-0112

PHA-2022-0013

Wal-Mart #10-2629, DS3508

7

CAS-2022-0025

PHA-2022-0006

Walgreens #12869, DS89777

8

CAS-2022-0252

PHA-2022-0038

Walgreens #1855, DS1418

9

CAS-2022-0253

PHA-2022-0046

Walgreens #13135, DS89732

10

CAS-2022-0254

PHA-2022-0041

Packard Pharmacy, DS373

11

CAS-2022-0276

PHA-2022-0050

Eterna Pharmacy, DS90272

12

CAS-2022-0275

PHA-2022-0052

Leslie's Pharmacy, DS3302

13

CAS-2022-0335

PHA-2022-0066

Walgreens #10639, DS3570

 14

CAS-2022-0287

PHA-2022-0060

Walgreens #17214, DS90117

 15

CAS-2022-0443

PHA-2022-0093

Walgreens #7329, DS3362

 16

CAS-2022-0336

SA-INV-19610

Walgreens #17605, DS90237

 17

CAS-2022-0336

PHA-2022-0071

William Collins, PH16711

 18

CAS-2022-0250

PHA-2022-0039

Rite Aid #10074, DS2895

 19

CAS-2022-0415

SA-INV-19753

Cardinal Health 110, WD352

 20

CAS-2022-0301

PHA-2022-0062

CVS #26, DS2912

21

CAS-2022-0519

PHA-2022-0108

CVS #26, DS2912

22

CAS-2022-0387

PHA-2022-0078

CVS #672, DS89987

23

CAS-2022-0240

PHA-2022-0044

CVS #2592, DS3011

24

CAS-2022-0523

PHA-2022-0113

CVS #2592, DS3011

25

CAS-2022-0023

PHA-2022-0007

CVS #1855, DS2901

26

CAS-2022-0195

SA-INV-19398

CVS #382, DS89637

27

CAS-2022-0238

PHA-2022-0043

CVS #2138, DS2815

28

CAS-2022-0341

SA-INV-19681

Walgreens #2330, DS1736

29

CAS-2022-0307

PHA-2022-0061

CVS #705, DS3428

30

CAS-2022-0280

PHA-2022-0054

CVS #117, DS3207

 

12:00

 

LUNCH BREAK

12:30

 

IX

EXECUTIVE SESSION

The Board will meet in Executive Session as authorized pursuant to M.G.L. c. 30A, § 21(a)(1) for the purpose of discussing the reputation, character, physical condition, or mental health, rather than professional competence, of an individual, or to discuss the discipline or dismissal of, or complaints or charges brought against, a public officer, employee, staff member or individual. Specifically, to evaluate the Good Moral Character as required for registration for a pending applicant.

1:00

X

M.G.L. c. 112, § 65C SESSION

3:30

XI

ADJOURNMENT

Feedback